Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesThe need and total cost of Finnish eyecare services: a simulation model for 2005-2040
Acta Ophthalmologica, 09/11/09
Tuulonen A et al. – The results of this modelling study indicate that policy initiatives, such as defining criteria for access to care, can have substantial implications on the demand for care and waiting times whereas the effect of ageing alone was relatively small. Measures to control several other factors such as the adoption and price level of new technologies, treatments and practice patterns will be at least equally important in order to restrain healthcare costs effectively.
Related Articles
The Resource Hub: an innovative e-information service delivery model addressing mental health knowledge management
Australasian Psychiatry, 10/07/09
Relevance Score: 46%
The demand for preventive care services and its relationship with inpatient services
Health Policy, 11/09/09
Relevance Score: 45%
Recent Changes in Medicaid Policy and Their Possible Effects on Mental Health Services
Psychiatric Services, 11/04/09
Relevance Score: 45%
Trust in Mental Health Services: A neglected concept
Journal of Mental Health, 10/19/09
Relevance Score: 45%
The Centers for Medicare and Medicaid Services Proposes Major Payment and Policy Changes
Gastroenterology, 10/05/09
Relevance Score: 45%
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia
Current Medical Research and Opinion, 12/18/09
Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia
Health Policy, 12/16/09
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor